CN1305492C - Leukemia treating Chinese medicinal composition - Google Patents
Leukemia treating Chinese medicinal composition Download PDFInfo
- Publication number
- CN1305492C CN1305492C CNB2005100442328A CN200510044232A CN1305492C CN 1305492 C CN1305492 C CN 1305492C CN B2005100442328 A CNB2005100442328 A CN B2005100442328A CN 200510044232 A CN200510044232 A CN 200510044232A CN 1305492 C CN1305492 C CN 1305492C
- Authority
- CN
- China
- Prior art keywords
- shares
- chinese medicine
- present
- medicine composition
- leukemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention discloses a traditional Chinese medicine for treating leukemia. The present invention is prepared from raw material of the following proportion by weight: 1 to 4 shares of natural indigo, 1 to 2 shares of madagascar periwinkle herb, 0.7 to 4 shares of common camptotheca fruit, 0.5 to 10 shares of tender catchweed bedstraw herb, 10 to 20 shares of semen torreyae bark, 15 to 30 shares of securinega suffruticosa and 2 to 4 shares of ovate tylophora root and rhizome. The present invention can effectively treat leukemia, and has the advantages of rapid effect taking, no side effect, high curative rate and no relapse after healing.
Description
Technical field the present invention relates to treat leukemic herbal composite, belongs to the Chinese medicine technical field.
The background technology leukemia is that pathological changes appears in the hemopoietic system of human body, is one of more refractory disease of blood system.Leukemic kind is a lot, for example Lymphocytic leukemia, monocytic leukemia, granulocyte leukemia, lympha tumour leukocythemia, megakaryocytic leukemia, have a liking for acid (alkali) chronic myeloid leukemia, erythroleukemia etc.Doctor trained in Western medicine generally adopts chemotherapy at present, and the toxic and side effects that chemotherapy produced to the human body infringement greatly, and the patient often can not get satisfied effect, but causes adverse consequencess such as health immunologic hypofunction on the contrary; And the bone marrow transplantation method that adopts, though can eradicate leukemia, can the probability that is harmonious owing to bone marrow is very low, many patients can not find suitable derived from bone marrow, and the bone marrow transplantation expense is very high, and the patient not only is difficult for accepting, and very painful.For avoiding the defective of western medical treatment, in China medical circles also the someone release herbal composite and treat leukemic scheme, but it is unreasonable on compatibility of drugs, so that pharmacology is obstructed, the Chinese herb medicine that has plays the illusion of respite only to leukemia, in very short time, the state of an illness is very fast to increase the weight of recurrence again, thereby these Chinese herb medicines can not reach the leukemic purpose of effective treatment.
Summary of the invention the objective of the invention is to be to overcome above-mentioned the deficiencies in the prior art, provides a kind of treatment leukemic Chinese medicine composition, and this Chinese medicine composition can effectively be treated leukemia, and has no side effect, instant effect, cure rate height, no longer recurrence after healing.
For realizing above-mentioned purpose of the present invention, the technical scheme that is adopted is: the leukemic Chinese medicine composition of a kind of treatment is characterized in that wherein making raw materials of effective components consists of:
Indigo Naturalis 1-4 part Herba Catharanthi Rosei 1-2 part Fructus Camptothecae Acuminatae 0.7-4 part Herba Galii Teneri 0.5-10 part
Bark of Cephalotaxus 10-20 part Cacumen Securinegae Suffruticosae 15-30 part Radix Et Rhizoma Tylophorae Ovatae 2-4 part.
For increasing the curative effect that the present invention treats Lymphocytic leukemia, can in above-mentioned prescription, add Radix Pseudostellariae 1-10 part.
For increasing the curative effect that the present invention treats granulocyte or megalokaryocyte and has a liking for acid (alkali) chronic myeloid leukemia, can in above-mentioned prescription, add: Herba Crotalariae sessiliflorae 1-4 part, Realgar 0.7-2 part, arsenicum sablimatum 1-5 part.
For increasing the curative effect that the present invention treats lympha tumour leukocythemia, can in above-mentioned prescription, add Radix Pseudostellariae 1-10 part, Hirudo 2-3 part.
For increasing the curative effect that the present invention treats erythrocyte leucocythemia, can in above-mentioned prescription, add cattle scalp glue 15-20 part.
The present invention preferably adopts conventional method to make oral liquid.
When adding Realgar and arsenicum sablimatum in the prescription, need earlier Realgar and arsenicum sablimatum to be processed into powder, when fluid temperature was reduced to room temperature, adding stirred and gets final product again.
Indigo Naturalis of the present invention has the effect of heat-clearing and toxic substances removing, removing heat from blood, removing fire from the liver; The Herba Catharanthi Rosei of being adopted has effects such as detoxicating and fighting cancer, suppressing the hyperactive liver blood pressure lowering; The Fructus Camptothecae Acuminatae that is adopted has removing blood stasis, controls effects such as cancer eliminating stagnation; Effect such as the Herba Galii Teneri that is adopted has cooling blood and removing stasis, stimulate the menstrual flow; Effect such as the bark of Cephalotaxus that is adopted has removing food stagnancy, moisturize; The Cacumen Securinegae Suffruticosae that is adopted has effects such as the nervus centralis of stimulation; The Radix Et Rhizoma Tylophorae Ovatae that is adopted has effects such as heat-clearing and toxic substances removing.These Chinese herb medicines organically are combined together, and not only can kill the cancerous cell in the blood effectively, and can also improve the autoimmune ability, the premunition of enhancing body, the quantity of platelet increasing, cool liver spleen.Therapeutic effect of the present invention is good, instant effect, and do not have negative interaction.Since 90 years, by adopting the treatment of Chinese medicine composition of the present invention to 32 patients, reached beyond thought remarkable result, effective percentage reaches 96%, and cure rate reaches 90%, no longer recurrence after healing.
And Radix Pseudostellariae of the present invention has enriching blood, effect such as promote the production of body fluid; Herba Crotalariae sessiliflorae has effects such as heat clearing away, detoxifcation; Realgar has effects such as counteracting toxic substances, parasite killing; Arsenicum sablimatum has effect such as rob expectorant, relieving asthma; Hirudo has effects such as blood circulation promoting and blood stasis dispelling; Cattle scalp glue has effect such as fill blood.These medicines are added in the compositions, can more can increase speed and effect that corresponding disease is cured.
Enumerate several concrete cases below, further specify effect of the present invention.
1, for certain, the woman, 54 years old, weak phenomenon appears in mid-June, 2000, and weak gradually heavy through general treatment, and it is pale face to occur.July 7, be: hemoglobin 69g/L, erythrocyte 2.3 * 10 through the hospital inspection result
12/ L, leukocyte 7.5 * 10
9/ L, platelet is 10 * 10
9/ L, lymphocyte is 52.1%, is diagnosed as acute lymphoblastic leukemia.After certain hospitalize more than a year, hepatosplenomegaly, pulse condition is loud, Guan Zhihong, yellow and greasy fur, the state of an illness increases the weight of, local visible tiny aubergine granule.Forward me subsequently to and treat, take the medicinal liquid of frying in shallow oil according to prescription of the present invention, just take effect significantly after three days, take two months after, the liver spleen is normal, tiny aubergine granule disappears.Assay is: erythrocyte 4 * 10
12/ L, leukocyte 4 * 10
9/ L, platelet is 120 * 10
9/ L, lymphocyte are 36.6%, substantially near normal.After this, continue to strengthen again and take medicine 3 years, do not see recurrence.
Method of administration is: per hour once, and each 50ml, one day 10 times.Consolidate period in a medicine,, took continuously one month at every turn according to method of administration, withdraw eight months after, took again one month, and then withdrew eight months, so go round and begin again, up to Man Sannian for extremely.
2, the week certain, the woman, 40 years old, heating, headache, night sweat appearred in August, 2000, cervical region has a little lymphadenectasis, the hospital inspection result is: leukocyte count is 20 * 10
9/ L, erythrocyte are 35 * 10
12/ L, platelet is 60 * 10
9/ L, lymphocyte is 61%, hospital is diagnosed as lymphoma leukemia, in hospital after treatment after a while, the state of an illness commentaries on classics of not getting better, and lymphadenovaris, hepatosplenomegaly, the body of the tongue dead color, tongue is greasy in vain.Change me March calendar year 2001 and treat, take the medicinal liquid of frying in shallow oil by prescription of the present invention, positive effect was promptly arranged after four days, take two months after, fully recover, assay is: erythrocyte 3.7 * 10
12/ L, leukocyte 5 * 10
9/ L, platelet is 105 * 10
9/ L, lymphocyte are 35%, continue to strengthen again and take medicine 3 years, and this patient is not recurrence so far.
Method of administration: with case 1.
3, Liu, the man, 39 years old, weak, hyperhidrosis, the anorexia of becoming thin, low grade fever, pale complexion, dizzy symptom repeatedly appearred in 1999, and assay is: leukocyte count is 36.7 * 10
9/ L, erythrocyte are 50 * 10
12/ L, platelet is 75.6 * 10
9/ L, granulocyte is 76.5%, is diagnosed as chronic myelocytic leukemia, after three week of hospitalize, hepatomegaly occurs, tormina, edema of lower limbs, purpura, nasal cavity and oral hemorrhage, hesitant pulse, purplish tongue, thin fur changes me afterwards over to and treats.Taking the medicinal liquid of frying in shallow oil by prescription of the present invention, was visible positive effect after four days, take two months after, fully recover.Assay is: leukocyte count is 7 * 10
9/ L, erythrocyte are 5 * 10
12/ L, platelet is 130 * 10
9/ L, granulocyte are 51.6%, and be normal substantially, continues to strengthen and take medicine 4 years, do not see recurrence so far.
Method of administration: with case 1.
4, surplus certain, the man, 40 years old, in April, 1997, shortness of breath and fatigue appearred, the extremity edema, skin has purpura, spontaneous perspiration, greasy urine, pale complexion, hospital is diagnosed as acute monocytic leukemia, through the hospital expectant treatment after half a year, the commentaries on classics of not getting better yet, and having increased the weight of.Assay is: leukocyte count is 37.8 * 10
9/ L, erythrocyte are 60.8 * 10
12/ L, platelet is 71.2 * 10
9/ L, mononuclear cell are 45.6%, and pulse condition is weak unable, and there is indentation on pale tongue and limit, white and moist fur, and change me over to and treat in November, 1997.Take the medicinal liquid of frying in shallow oil by prescription of the present invention, positive effect was promptly arranged after three days, continue to take medicinal liquid of the present invention after two months, normal substantially, assay is: leukocyte count is 7 * 10
9/ L, erythrocyte are 5 * 10
12/ L, platelet is 120 * 10
9/ L, mononuclear cell are 6.8%.Continue to strengthen again and take medicine 3 years, do not see recurrence so far.
Method of administration: with case 1.
5, Cui, the woman, 47 years old, in February, 92, dizzy, the purple point of seriousness appearred, and general weakness, pale complexion, assay is: leukocyte count is 30 * 10
9/ L, erythrocyte are 1.5 * 10
12/ L, platelet is 73 * 10
9/ L, myeloblast are 41.5%, pulse condition flood number, and red tongue, no fur is a hypoplastic acute leukemia through hospital diagnosis.In May, 92, I treated, and took the medicinal liquid of frying in shallow oil by prescription of the present invention, and positive effect was promptly arranged after three days, continued to take medicinal liquid of the present invention after two months, and am normal substantially.Assay is: leukocyte count is 5.1 * 10
9/ L, erythrocyte are 4.1 * 10
12/ L, platelet is 135 * 10
9/ L, myeloblast are 1.8%.Continue to strengthen again and take medicine 3 years, do not see recurrence so far.
Method of administration: with case 1.
6, in certain, the woman, 18 years old, 94 years inboard no characteristic of disease lumps (chloroma) that occur of its eye socket, after exposing in the sun, marennin disappears rapidly, and with weak, pale complexion, constipation, giddy.Assay is: leukocyte count is 185 * 10
9/ L, erythrocyte are 31.6 * 10
12/ L, platelet is 71.9 * 10
9/ L, granulocyte are 75.6%, and pulse condition is thin and unable, and few tongue of tongue and color are light, and hospital diagnosis is a chloroma leucocythemia.My diagnosis and treatment of in February, 95 are treated, and take the medicinal liquid of frying in shallow oil by prescription of the present invention, and positive effect was promptly arranged after three days, continue to take medicinal liquid of the present invention after two months, and are normal substantially.Assay is: leukocyte count is 6.12 * 10
9/ L, erythrocyte are 4.1 * 10
12/ L, platelet is 115 * 10
9/ L, granulocyte are 46.8%.Continue to strengthen again and take medicine 4 years, do not have repeatedly so far.
Method of administration: with case 1.
7, grandson, the man, 52 years old, 95 years its costalgias, fatigue and weak, anemia, liver, spleen and lymphadenectasis, urine protein is determined as the positive, and assay is: leukocyte count is 71.8 * 10
9/ L, erythrocyte are 56.7 * 10
12/ L, platelet is 67.1 * 10
9/ L, plasma cell are 75%, and pulse condition is carefully unable, red tongue, and greasy fur, hospital diagnosis are Plasmacytic leukemia.In the January, 96 I treat, take the medicinal liquid of frying in shallow oil by prescription of the present invention, positive effect was promptly arranged after three days, continue to take medicinal liquid of the present invention after two months, normal substantially, assay is: leukocyte count is 7.65 * 10
9/ L, erythrocyte are 5.43 * 10
12/ L, platelet is 120 * 10
9/ L, plasma cell are 2.1%, continue to strengthen again and take medicine 4 years, do not have repeatedly so far.
Method of administration: with case 1.
The specific embodiment is done further detailed description below in conjunction with the concrete example of implementing to the present invention.
Embodiment 1: take by weighing Indigo Naturalis 10Kg, Herba Catharanthi Rosei 10Kg, Fructus Camptothecae Acuminatae 7Kg Herba Galii Teneri 5Kg, bark of Cephalotaxus 100Kg, Cacumen Securinegae Suffruticosae 150Kg, Radix Et Rhizoma Tylophorae Ovatae 20Kg, after the mixing, make medicine oral liquid according to a conventional method.
Embodiment 2: take by weighing Indigo Naturalis 40Kg, Herba Catharanthi Rosei 20Kg, Fructus Camptothecae Acuminatae 40Kg, Herba Galii Teneri 100Kg, bark of Cephalotaxus 200Kg, Cacumen Securinegae Suffruticosae 30Kg, Radix Et Rhizoma Tylophorae Ovatae 40Kg, after the mixing, make medicine oral liquid according to a conventional method.
Embodiment 3: take by weighing Indigo Naturalis 25Kg, Herba Catharanthi Rosei 15Kg, Fructus Camptothecae Acuminatae 23Kg, Herba Galii Teneri 52Kg bark of Cephalotaxus 150Kg, Cacumen Securinegae Suffruticosae 225Kg, Radix Et Rhizoma Tylophorae Ovatae 30Kg, after the mixing, make medicine oral liquid according to a conventional method.
Embodiment 4: take by weighing Indigo Naturalis 10Kg, Herba Catharanthi Rosei 15Kg, Fructus Camptothecae Acuminatae 40Kg, Herba Galii Teneri 50Kg, bark of Cephalotaxus 15Kg, a leaf 200Kg, Radix Et Rhizoma Tylophorae Ovatae 40Kg, after the mixing, make medicine oral liquid according to a conventional method.
Embodiment 5: for granulocyte or megalokaryocyte and have a liking for acid (alkali) chronic myeloid leukemia, can add respectively in embodiment 1-4: Herba Crotalariae sessiliflorae 10-40Kg, Realgar 7-20Kg, arsenicum sablimatum 10-50Kg.Herba Crotalariae sessiliflorae with after other raw material among the embodiment 1-4 mixes, is made medicine oral liquid according to a conventional method, Realgar, arsenicum sablimatum are processed into powder, adding stirs in the medicine oral liquid under the room temperature again gets final product.
Embodiment 6: for Lymphocytic leukemia, can add Radix Pseudostellariae 10-100Kg respectively in embodiment 1--4.
Embodiment 7: for lympha tumour leukocythemia, can add Radix Pseudostellariae 10-100Kg, Hirudo 20-30Kg respectively in embodiment 1--4.
Embodiment 8: for erythrocyte leucocythemia, can add cattle scalp glue 150-200Kg respectively in embodiment 1-4.
Claims (5)
1, the leukemic Chinese medicine composition of a kind of treatment is characterized in that wherein making raw materials of effective components consists of:
Indigo Naturalis 1-4 part Herba Catharanthi Rosei 1-2 part Fructus Camptothecae Acuminatae 0.7-4 part Herba Galii Teneri 0.5-10 part
Bark of Cephalotaxus 10-20 part Cacumen Securinegae Suffruticosae 15-30 part Radix Et Rhizoma Tylophorae Ovatae 2-4 part.
2, according to the leukemic Chinese medicine composition of the described treatment of claim 1, it is characterized in that adding Radix Pseudostellariae 1-10 part.
3,, it is characterized in that adding: Herba Crotalariae sessiliflorae 1-4 part, Realgar 0.7-2 part, arsenicum sablimatum 1-5 part according to the leukemic Chinese medicine composition of the described treatment of claim 1.
4, according to the leukemic Chinese medicine composition of the described treatment of claim 1, it is characterized in that adding Radix Pseudostellariae 1-10 part, Hirudo 2-3 part.
5, according to the leukemic Chinese medicine composition of the described treatment of claim 1, it is characterized in that adding cattle scalp glue 15-20 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100442328A CN1305492C (en) | 2005-08-11 | 2005-08-11 | Leukemia treating Chinese medicinal composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100442328A CN1305492C (en) | 2005-08-11 | 2005-08-11 | Leukemia treating Chinese medicinal composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1733008A CN1733008A (en) | 2006-02-15 |
| CN1305492C true CN1305492C (en) | 2007-03-21 |
Family
ID=36075763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100442328A Expired - Fee Related CN1305492C (en) | 2005-08-11 | 2005-08-11 | Leukemia treating Chinese medicinal composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1305492C (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1333050A (en) * | 2001-07-06 | 2002-01-30 | 张光新 | Traditional Chinese medicine for treating cancer |
| CN1615970A (en) * | 2004-09-15 | 2005-05-18 | 中国人民解放军第210医院 | Chinese medicine preparation compound Huangdai tablet for treating leukemia and its jpreparing method |
-
2005
- 2005-08-11 CN CNB2005100442328A patent/CN1305492C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1333050A (en) * | 2001-07-06 | 2002-01-30 | 张光新 | Traditional Chinese medicine for treating cancer |
| CN1615970A (en) * | 2004-09-15 | 2005-05-18 | 中国人民解放军第210医院 | Chinese medicine preparation compound Huangdai tablet for treating leukemia and its jpreparing method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1733008A (en) | 2006-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102743665B (en) | Chinese medicinal composition for promoting healing after boneblast, as well as preparation method and application thereof | |
| CN1823972A (en) | Medicine for treating celevical vertebra disease | |
| CN101066394A (en) | Externally applied medicine for treating infantile pneumonitis, bronchitis and asthma | |
| CN1840124A (en) | Chinese medicine for treating bone injury | |
| CN101904916B (en) | Medicine for treating diabetes radically and preparation method thereof | |
| CN1268385C (en) | Chinese medicinal for epilepsy and insanity | |
| CN1305492C (en) | Leukemia treating Chinese medicinal composition | |
| CN115814046A (en) | Traditional Chinese medicine composition for treating mastitis and application thereof | |
| CN1861183A (en) | Traditional Chinese medicine capsule for treating mammary gland diseases | |
| CN1843443A (en) | Rheumatoid disease treating plaster | |
| CN106344772A (en) | traditional Chinese medicine composition for treating rhinitis, external preparation and preparation method thereof | |
| CN1686348A (en) | Medicine for scarless treating external wound and operation cut wound | |
| CN100341563C (en) | Chinese medicinal capsule for treating metrorrhagia and metrostaxis | |
| CN103127391B (en) | Drug for curing blood diseases and preparation method thereof | |
| CN1613471A (en) | Preparation of compound pseudo-ginseng drop pellets for treating traumatologic disease | |
| CN101108234A (en) | Traditional Chinese medicine composition treating megakaryocytic leukemia | |
| CN101108215A (en) | Traditional Chinese medicine composition for treating lympha tumour leukocythemia | |
| CN101596255B (en) | Chinese medicament for preventing and curing leucemia | |
| CN101108218A (en) | Traditional Chinese medicine composition for treating granular leukocyte leukocythemia | |
| CN1927260A (en) | Application of walnut oil in pharmaceutical preparation for preventing and treating osteoporosis | |
| CN101108216A (en) | Traditional Chinese medicine composition for treating rubricyte leukocythemia | |
| CN101433662A (en) | Prescription containing double formulas for quickly treating scrofula and processing | |
| CN1895314A (en) | A lyophilized powder for injection containing Notoginseng radix total saponin with good appearance and shatter resistance, and its preparation method | |
| CN102908562B (en) | Traditional Chinese medicine combination for treating breast diseases and preparation method thereof | |
| CN101108217A (en) | Chinese medicinal herb for treating hemopathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070321 Termination date: 20100811 |